These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 53697)
1. Letter: Rosette-forming lymphocytes in cervical in-situ carcinoma. Ashman R; Johnson K; Nahmias A Lancet; 1975 Dec; 2(7946):1212. PubMed ID: 53697 [No Abstract] [Full Text] [Related]
2. Cellular immunity in carcinoma of the uterine cervix. Lambert B; Boushira M; Pelletier M; Montplaisir S Gynecol Oncol; 1984 Mar; 17(3):394-5. PubMed ID: 6608476 [No Abstract] [Full Text] [Related]
3. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)]. Ishiguro T Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426 [TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immunity in cervical intraepithelial neoplasia. Park TK; Kim SN; Choi DH; Lee CH Asia Oceania J Obstet Gynaecol; 1992 Jun; 18(2):171-5. PubMed ID: 1503541 [TBL] [Abstract][Full Text] [Related]
5. Immunological abnormalities in patients with cervical carcinoma. Castello G; Esposito G; Stellato G; Dalla Mora L; Abate G; Germano A Gynecol Oncol; 1986 Sep; 25(1):61-4. PubMed ID: 3732919 [TBL] [Abstract][Full Text] [Related]
6. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ. Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724 [TBL] [Abstract][Full Text] [Related]
7. [Suppression of cellular immunity in patients with carcinoma in situ and microinvasive cancer of the cervix uteri]. Marinova-Mutafchieva LP; Chakalova GB; Goranov IT Vopr Onkol; 1991; 37(4):454-7. PubMed ID: 1832253 [TBL] [Abstract][Full Text] [Related]
8. T and B lymphocytes in patients with squamous cell carcinoma of the uterine cervix. Ishiguro T; Sugitachi I; Katoh K Gynecol Oncol; 1980 Feb; 9(1):80-5. PubMed ID: 6965486 [No Abstract] [Full Text] [Related]
9. [Blast transformation of the peripheral lymphocytes in cervical cancer during the radiotherapy process]. Shiriĭ AV Vopr Onkol; 1975; 21(3):35-40. PubMed ID: 1130018 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of cellular immunity in precancerous conditions and in carcinoma of the portio]. Bolis PF; Polatti F; Zara C Minerva Ginecol; 1979 Jun; 31(6):445-7. PubMed ID: 315039 [No Abstract] [Full Text] [Related]
11. [Control of the immunological reactivity in cervical cancer in the process of radiation therapy]. Shiriĭ AV Vopr Onkol; 1979; 25(1):63-8. PubMed ID: 311545 [TBL] [Abstract][Full Text] [Related]
12. Impairment of rosette forming T-lymphocytes in carcinoma of cervix uteri. Utreja SR; Ramdeo IN; Kalra VB; Lodha SK; Sareen PM Indian J Cancer; 1980 Dec; 17(4):216-9. PubMed ID: 6971798 [No Abstract] [Full Text] [Related]
13. Importance of Langerhans cells in the immune origin of carcinoma of the uterine cervix. Bonilla-Musoles F; Castells A; Simón C; Serra V; Pellicer A; Ramírez A; Pardo G Eur J Gynaecol Oncol; 1987; 8(1):44-60. PubMed ID: 3552682 [TBL] [Abstract][Full Text] [Related]
14. Carcinoma in situ: behavior patterns and cytoimmunology. Induced regression by an immunoactive coupled tumor protein antigen. Ayre JE; Narvaez R Oncology; 1973; 27(4):294-304. PubMed ID: 4716876 [No Abstract] [Full Text] [Related]
15. E-rosette forming lymphocytes in carcinoma of uterine cervix patients before and after treatment. Singh RP; Shukla M; Singh VP; Udupa KN J Assoc Physicians India; 1987 Mar; 35(3):211-2. PubMed ID: 3497155 [No Abstract] [Full Text] [Related]
16. Letter: Rosette-forming T-lymphocytes in malnutrition. Rabson AR; Geefhuyzen J; Rosen EU; Joffe M Br Med J; 1975 Jan; 1(5948):40. PubMed ID: 1078985 [No Abstract] [Full Text] [Related]
17. Cell-mediated immune responses to cytomegalovirus in patients with dysplasia of the uterine cervix. Neill WA; Norval M Gynecol Obstet Invest; 1985; 20(2):96-102. PubMed ID: 2997004 [TBL] [Abstract][Full Text] [Related]